In high-grade gliomas, including glioblastoma (GBM), LDHA expression is significantly elevated compared with low-grade gliomas [8,9], and its overexpression has been linked to resistance to radiotherapy and chemotherapy, particularly temozolomide [10]. Here, LDHA is linked to central nervous system cancer.